Copyright
©The Author(s) 2023.
World J Gastroenterol. Apr 14, 2023; 29(14): 2134-2152
Published online Apr 14, 2023. doi: 10.3748/wjg.v29.i14.2134
Published online Apr 14, 2023. doi: 10.3748/wjg.v29.i14.2134
Figure 5 Target-disease network of carrimycin.
The 293 predicted target proteins were analyzed one by one by combining multiple databases to screen 77 main targets (circles) and 22 main diseases (rectangles). The main diseases involved were liver cancer (degree = 18), breast cancer (degree = 13), lung cancer (degree = 12), and prostate cancer (degree = 10). HCC: Hepatocellular carcinoma.
- Citation: Li XY, Luo YT, Wang YH, Yang ZX, Shang YZ, Guan QX. Anti-inflammatory effect and antihepatoma mechanism of carrimycin. World J Gastroenterol 2023; 29(14): 2134-2152
- URL: https://www.wjgnet.com/1007-9327/full/v29/i14/2134.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i14.2134